Sarcopenia
Conditions
Keywords
hemodialysis, nutrition, exercise
Brief summary
Sarcopenia can be easily observed in patients with hemodialysis. However, there were few studies on the precise concept and diagnostic criteria for sarcopenia in patients with hemodialysis. The investigators have already recognized the sarcopenia-associated mortality and morbidity in patients with hemodialysis. However, intervention studies on hemodialysis patients with sarcopenia have not been conducted until now. In 2021, the investigators conducted a pilot study to evaluate the effectiveness of the combined exercise and nutrition intervention for sarcopenia in patients with hemodialysis to confirm the effectiveness. This study is a follow-up study, conducted as a randomized controlled trial.
Detailed description
This is a prospective, 1:1 randomized controlled study with 40 patients with hemodialysis who were diagnosed as sarcopenia or frailty in our previous cohort study. Combined intervention will consist of resistance exercise and nutritional supplementation for 12 weeks. The primary outcome of this study is muscle mass and handgrip strength after 12 weeks' intervention. All functional outcomes will be measured at 0, 4, 8 and 12 weeks after intervention. The data will be analysed using the intention-to-treat principle.
Interventions
resistance exercise and protein supplementation including branched chain amino acids for 12 weeks
Sponsors
Chungnam National University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients with hemodialysis * Community-dwellers * Able to walk with or without assistive devices for more than 100 meters
Exclusion criteria
* A person with cancer disease. * People with psychiatric symptoms. * A person who has an absorption disorder or has a history of resection of the small intestine or colon * Pregnant women * A person treated for acute bacterial infections * A person who is in a wheelchair due to inconvenience in walking.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Handgrip strength in Kg using a portable dyanometer | 12 weeks | Measurement of handle strength using a portable dynamometer to view the function of skeletal muscle every 4 weeks. |
| Body composition using dual energy x-ray absorptiometry (DXA) | 12 weeks | Body composition will be evaluated by dual energy x-ray absorptiometry at start and end of the study. |
| Body composition using body composition monitor (BCM) | 12 weeks | Body composition will be evaluated by bioimpedence analysis using body composition monitor start at and end of the study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The total score of Short Physical Performance Battery(SPPB) | 12 weeks | The total score is the sum of 5 times Chair Stand Test(CST) score and balance test score and gait speed test score for 4meter. |
| The second of 5 times Chair Stand Test | 12 weeks | Pre test, participants fold their arms across their chest and try to stand up once from a chair. And Measures the time required to perform five rises from a chair to an upright position as fast as possible without the use of the arms. |
| skeletal muscle mass index(SMI) in cm2/m2 | 12 weeks | The SMI was calculated according to the following formula: skeletal muscle mass (cm 2) / height 2 (m 2). |
| Glucose pattern using continuous glucose monitoring system(freestyle libre) | 12 weeks | Blood glucose is measured using continuous glucose monitoring system(freestyle libre) at start and end of the study. |
Countries
South Korea
Contacts
CONTACTHyon-Seung Yi
STUDY_CHAIRHyon-Seung Yi
Chungnam National University Hospital
Outcome results
None listed